Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr David Cranston, Consultant Urological Surgeon, Clinical Director High Intensity Focused Ultrasound Unit, Nuffield Department of Surgical Sciences and Fellow Of Green Templeton College Oxford, has recently published the book "John Radcliffe and his Legacy to Oxford."

Book coverJohn Radcliffe is a name known to every Oxford resident. The hospital bears his name, and the Radcliffe Camera is but one monument to his legacy. But who was he? What sort of doctor was he, and whom did he treat? How did he manage to amass such a fortune and bestow his name and influence on so much of the city? David Cranston’s short book tells the story of John Radcliffe and the legacy he left behind.

Professor Sir David Watson, Principal, Green Templeton College commented: “John Radcliffe’s bequests have changed the face of historical Oxford, and their effects live on. Green Templeton College Fellow David Cranston has performed a valuable service, in the tercentenary year of the Doctor’s death, by showing how and why this came about.  As the College views the 21st century physical evolution of Oxford University, from the commanding heights of the Radcliffe Observatory, it is salutary to reflect on how science, medicine, management and architecture have made use of this legacy, and continue to do so through our work in education, research and public service.”

Sir Roger Bannister, a former Radcliffe Travelling Fellow said: “I am delighted as a physician to commend a book written by a surgeon about a physician. In 1960 I had the good fortune to benefit from one of John Radcliffe’s many acts of generosity to Oxford University. Holding a John Radcliffe Medical Travelling Fellowship, I spent a year at Harvard as part of my training to become a Consultant Neurologist. In the 18th century, Radcliffe Medical Fellows commonly went to the European centres of medical excellence, such as Bologna in Italy. That wise and robust sage, Dr Samuel Johnson, remarked that they and their patients might benefit more if they visited underdeveloped parts of the world such as South America, to study treatments and drugs outside Britain and Europe. Had they taken his advice, we might have benefited two centuries earlier from a wide range of drugs discovered in South America, such as curare”.

Further information: 

To order visit www.wordsbydesign.co.uk and follow the ‘books for sale’ link.

John Radcliffe and his Legacy to Oxford by David Cranston, with illustrations by Valerie Petts (ISBN: 978-1-909075-18-4)

Dr Cranston's webpage

Similar stories

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Coronavirus COVID-19 General Research

In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.